CardioNet Access
CardioNet PEMS
LifeWatch Connect
MedNet Access
INR Physician Portal
BioTel Research Cardiac Safety Portal
Improving the Quality of Care While Reducing Costs
Our remote monitoring technology has helped us build the world’s largest cardiac data network, making care more accurate, comprehensive and efficient.
4,000,000,000+
Processing over 4 billion heartbeats a day
1,000,000+
Monitoring over 1 Million patients per year
30,000+
Each month more than 30,000 physicians refer patients to our products
1,000,000+
Provided over 1 million reports to physicians with information for diagnosis and therapy management
50,000+
Over 50,000 monitoring devices – 29 U.S. patents and 34 international patents issued
$300,000,000+
Over $300 million invested in the technology and service platform
BioTel Heart is the leading provider of remote cardiac monitoring diagnostic services.
Need help with your heart monitor?
Find product details, quick start guides and more at myheartmonitor.com.
BioTel Research is an industry leader in clinical trials testing services, monitoring, data, and scientific consulting.
Latest News
BioTelemetry, Inc. to Release Second Quarter 2018 Earnings Results on July 25, 2018
MALVERN, Pa., July 17, 2018 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2018 earnings on Wednesday, July 25 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, July 25, 2018. The broadcast will be available through the investor information section of […]
July 17, 2018
MALVERN, Pa., June 13, 2018 (GLOBE NEWSWIRE) — (NASDAQ:BEAT) – BioTel CareTM (formally known as Telcare), a BioTelemetry company, announced today the release of its next-generation wireless blood glucose monitor for diabetes management. As an industry pioneer, BioTel Care developed the first FDA-cleared, cellular-enabled glucometer which supports real-time transmission and consolidation of patient data in an […]
June 13, 2018
BioTelemetry, Inc. Reports First Quarter 2018 Financial Results
Company Exceeds Revenue and Adjusted EBITDA Expectations MALVERN, Pa., April 25, 2018 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2018. Company […]
April 25, 2018